CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Legal Officer sold 9,492 shares at $21.96 ($208,421)
- 4 Open-market sale Chief Medical Officer sold 51,914 shares at an average $22.01 ($1,142,375)
- 4 Open-market sale Chief Legal Officer sold 45,119 shares at an average $22.10 ($996,963)
- 4 Open-market sale Chief Scientific Officer sold 21,790 shares at an average $21.64 ($471,437)
- 4 Open-market sale Chief Financial Officer sold 15,037 shares at an average $21.64 ($325,383)
- 4 Open-market sale President and CEO sold 33,260 shares at an average $21.64 ($719,735)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Legal Officer sold 20,416 shares at an average $23.45 ($478,845)
- 4 Open-market sale Chief Legal Officer sold 45,000 shares at an average $24.08 ($1,083,718)
- 4 Open-market sale Chief Financial Officer sold 87,339 shares at an average $26.45 ($2,310,106)
- 4 Open-market sale President and CEO sold 30,000 shares at $26.84 ($805,239)
- 4 Shares withheld for taxes Chief Medical Officer gave up 7,940 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 6,840 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 10,177 shares (to pay taxes)
Page 10 of 21 · 414 filings